David Arkowitz
Chief Operating Officer
Health care
Visterra
Denmark
Biography
David Arkowitz has more than 20 years of finance and operations leadership experience in the healthcare, life sciences and biotechnology industries. Prior to joining Visterra, Mr. Arkowitz was at Mascoma Corporation, a bioconversion company, where he served as Chief Financial Officer and General Manager, Mascoma Grain Tech. Previously, he was Chief Financial Officer and Chief Business Officer of AMAG Pharmaceuticals, a commercial stage public biopharmaceutical company, where he had a broad range of operational and general management responsibilities. Prior to his tenure at AMAG, he served as Chief Financial Officer of Idenix Pharmaceuticals where he managed the company's initial public offering. Earlier in his career, he spent more than thirteen years at Merck & Co. including as Vice President and Controller of the U.S. sales and marketing division and as Controller of the global research and development division. Mr. Arkowitz serves on the board of directors and as Chair of the audit committee of Spring Bank Pharmaceuticals, Inc., a public biopharmaceutical company. He has a BA in Mathematics from Brandeis University and an MBA from Columbia University.
Research Interest
health care
